Mankind Pharma Limited (NSE:MANKIND)
India · Delayed Price · Currency is INR 2,226.90
-20.10 (-0.89%)
Nov 18, 2025, 3:29 PM IST
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 919.17 billion as of November 18, 2025. Its market cap has decreased by -5.46% in one year.
Market Cap
919.17B
Enterprise Value
970.30B
Revenue
135.46B
Ranking
n/a
PE Ratio
52.31
Stock Price
2,226.90
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 919.17B, an increase of 61.33%. That is a compound annual growth rate of 20.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 927.47B | -21.95% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.22T |
| Divi's Laboratories | 1.73T |
| Cipla | 1.24T |
| Apollo Hospitals Enterprise | 1.07T |
| Zydus Lifesciences | 950.34B |
| Aurobindo Pharma | 710.03B |
| Fortis Healthcare | 707.92B |
| Alkem Laboratories | 684.21B |